BioMarin Pharmaceutical Inc. (BMRN) 2015年年度报告「NASDAQ」.pdf

1、BIOMARIN PHARMACEUTICAL INCFORM 10-K(Annual Report)Filed 02/29/16 for the Period Ending 12/31/15 Address105 DIGITAL DRIVENOVATO,CA 94949Telephone4155066700CIK0001048477SymbolBMRNSIC Code2834-Pharmaceutical PreparationsIndustryBiotechnology&DrugsSectorHealthcareFiscal Year12/31http:/www.edgar- Copyri

2、ght 2016,EDGAR Online,Inc.All Rights Reserved.Distribution and use of this document restricted under EDGAR Online,Inc.Terms of Use.ffUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form 10-K(Mark One)xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1

3、934For the fiscal year ended December 31,2015OrTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to .Commission file number:000-26727BioMarin Pharmaceutical Inc.(Exact name of registrant as specified in its charter)Delaware68-039782

4、0(State of other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)770 Lindaro Street San Rafael,California94901(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:(415)506-6700Securities registered pursuant to Section 12(

5、b)of the Act:Title of Each ClassName of Each Exchange on Which RegisteredCommon Stock,$.001 par valueThe NASDAQ Global Select MarketSecurities registered under Section 12(g)of the Act:NoneIndicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct.YesxNoIndicat

6、ebycheckmarkiftheregistrantisnotrequiredtofilereportspursuanttoSection13orSection15(d)oftheAct.YesNoxIndicatebycheckmarkwhethertheregistrant(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasreq